Massachusetts Climate and Biotech Funding Bifurcate

Form Energy reportedly raised a $750M Series G to scale 100-hour iron-air storage, but manufacturing and deployment economics remain unproven. In biotech, TScan’s 75% workforce reduction and paused Phase 3 contrast with BrainChild Bio’s reported approximately $119M Series A for a pivotal pediatric brain-cancer CAR-T study, highlighting capital preference for differentiated programs and late-stage risk reduction.